D.C. Circuit Court Affirms FDA Misclassified Contrast Agent As A Drug
Mealey's (May 18, 2021, 8:26 AM EDT) -- WASHINGTON, D.C. — The District of Columbia Circuit U.S. Court of Appeals on April 16 said the Food and Drug Administration erred when it classified a contrast agent as a drug...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login